HOME
市場調査レポート
研究用抗体(Research Antibodies)の世界市場2020-2027年：技術別、研究領域別予測
Research Antibodies Market Size, Share & Trends Analysis Report By Type (Monoclonal, Polyclonal), By End Use, By Product, By Technology, By Source, By Application (Oncology, Stem Cells), And Segment Forecasts, 2020 - 2027
- 出版元：Grand View Research
出版元について - 発行年：2020年2月
- 定価 Single User License(1名様ライセンス)US$5,950(米国ドル)/Multi User License(5名様)$6,950 /Enterprise License $8,950
- ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
- ご請求は円換算（お見積り日TTSレート）となります。
- 納品形態：PDF by Email
- 当調査レポートは英文142ページになります。
- 商品コード：GRAN124
お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。
【レポート紹介】
研究用抗体の世界市場規模は2019年の推計34億ドルから、このさき2027年には56億ドルへと漸増が予測されます。当レポートでは、2027年に至る研究用抗体の世界市場予測(市場規模US$)、プロダクト別市場（一次抗体、二次抗体）、タイプ別市場（モノクローナル抗体、ポリクローナル抗体）、技術別市場（免疫組織化学、免疫蛍光、ウエスタンブロッティング、フローサイトメトリー、免疫沈降、ELISA、その他技術）、由来別市場（マウス、ウサギ、ヤギ、その他由来）、研究領域別市場（感染症、免疫学、腫瘍学、幹細胞、神経生物学、その他研究領域）、エンドユース別市場（学術/研究機関、受託研究機関、製薬/バイオテクノロジー企業）、主要国地域別市場など、詳細な市場予測データと分析を掲載しています。また市場分析、競合状況、主要メーカー企業10社プロフィール動向などの情報も交えて、研究用抗体市場の現在と今後展開を予測分析していきます。
【レポート構成概要】 
◆研究用抗体の世界市場予測2016-2027年
・市場規模(US$)
◆プロダクト別、市場-2027年
・一次抗体
・二次抗体
※(市場規模US$)
◆タイプ別、市場-2027年
・モノクローナル抗体
・ポリクローナル抗体
※(市場規模US$)
◆技術別、市場-2027年
・免疫組織化学
・免疫蛍光
・ウエスタンブロッティング
・フローサイトメトリー
・免疫沈降
・ELISA
・その他技術
※(市場規模US$)
◆由来別、市場-2027年
・マウス
・ウサギ
・ヤギ
・その他由来
※(市場規模US$)
◆研究領域別、市場-2027年
・感染症
・免疫学
・腫瘍学
・幹細胞
・神経生物学
・その他研究領域
※(市場規模US$)
◆エンドユース別、市場-2027年
・学術/研究機関
・受託研究機関
・製薬/バイオテクノロジー企業
※(市場規模US$)
◆主要国地域別市場-2027年
北米
・米国、カナダ
欧州
・ドイツ、英国、スペイン
・フランス、イタリア、ロシア
アジア太平洋
・日本、中国、インド、韓国
・オーストラリア、シンガポール
中南米
・ブラジル、メキシコ、アルゼンチン
中東アフリカ
・南アフリカ
・サウジアラビア、アラブ首長国連邦
※国地域別に全てのセグメント別の細分化データ掲載、詳細は目次参照
◆市場分析
・市場分析（ドライバー、障壁）
・ファイブフォース分析
・PESTEL分析
・競合状況
◆研究用抗体の主要企業プロフィール動向
・ABCAM PLC
・BIO - RAD LABORATORIES
・BD
・MERCK MILLIPORE
・LONZA GROUP
・THERMO FISHER SCIENTIFIC
・CELL SIGNALLING TECHNOLOGY, INC.
・F.HOFFMANN LA ROCHE LTD.
・AGILENT TECHNOLOGIES
・PERKINELMER, INC.
（全142頁）
【レポート詳細目次、データ項目一覧は当ページ下を参照ください】
英文詳細目次(table of contents)
【原文詳細目次】
Research Antibodies Market Size, Share & Trends Analysis Report By Type (Monoclonal, Polyclonal), By End Use, By Product, By Technology, By Source, By Application (Oncology, Stem Cells), And Segment Forecasts, 2020 - 2027
Table of Contents
CHAPTER 1 METHODOLOGY AND SCOPE
1.1 MARKET SEGMENTATION & SCOPE
1.2 MARKET DEFINITION
1.3 INFORMATION PROCUREMENT
1.3.1 PURCHASED DATABASE
1.3.2 GVR’S INTERNAL DATABASE
1.3.3 SECONDARY SOURCES & THIRD PARTY PERSPECTIVES
1.3.4 PRIMARY RESEARCH
1.4 INFORMATION ANALYSIS
1.4.1 DATA ANALYSIS MODELS
1.5 MARKET FORMULATION & DATA VISUALIZATION
CHAPTER 2 EXECUTIVE SUMMARY
2.1 MARKET OUTLOOK
2.2 SEGMENT OUTLOOK
2.3 COMPETITIVE INSIGHTS
CHAPTER 3 RESEARCH ANTIBODIES MARKET VARIABLES, TRENDS & SCOPE
3.1 MARKET LINEAGE OUTLOOK
3.1.1 PARENT MARKET OUTLOOK
3.1.2 ANCILLARY MARKET OUTLOOK
3.2 PENETRATION AND GROWTH PROSPECT MAPPING
3.2.1 USER PERSPECTIVE ANALYSIS
3.2.1.1 CONSUMER BEHAVIOR ANALYSIS
3.3 REGULATORY FRAMEWORK
3.3.1 REIMBURSEMENT FRAMEWORK
3.3.2 STANDARDS AND COMPLIANCES
3.4 MARKET DYNAMICS
3.4.1 MARKET DRIVER ANALYSIS
3.4.1.1 INCREASING INVESTMENT IN R&D
3.4.1.2 GROWING STEM CELLS AND NEUROBIOLOGY RESEARCH
3.4.1.3 INCREASE IN RESEARCH ACADEMIES AND INDUSTRY COLLABORATIONS
3.4.1.4 RISE IN THE AVAILABILITY OF TECHNOLOGICALLY ADVANCED PRODUCTS
3.4.1.5 RISE IN PROTEOMICS AND GENOMICS RESEARCH
3.4.2 MARKET RESTRAINT ANALYSIS
3.4.2.1 STRINGENT GOVERNMENT REGULATIONS
3.4.2.2 HIGH COST OF RESEARCH ANTIBODIES
3.4.3 MARKET OPPORTUNITIES ANALYSIS
3.4.3.1 INCREASING OPPORTUNITIES IN VARIOUS EMERGING MARKETS
3.4.3.2 GROWING DEMAND FOR PERSONALIZED MEDICINES
3.4.3.3 RISING FOCUS ON BIOMARKER DISCOVERY
3.4.4 MARKET CHALLENGES ANALYSIS
3.4.4.1 QUALITY CONCERNS OF RESEARCH ANTIBODIES
3.4.4.2 TIME AND COST INTENSIVE PROCESS OF ANTIBODY DEVELOPMENT
3.4.4.3 PRICING PRESSURES FACED BY MAJOR MARKET PLAYERS
3.5 RESEARCH ANTIBODIES MARKET ANALYSIS TOOLS
3.5.1 INDUSTRY ANALYSIS - PORTER’S
3.5.1.1 SUPPLIER POWER
3.5.1.2 BUYER POWER
3.5.1.3 SUBSTITUTION THREAT
3.5.1.4 THREAT FROM NEW ENTRANTS
3.5.1.5 COMPETITIVE RIVALRY
3.5.2 PESTEL ANALYSIS
3.5.2.1 POLITICAL LANDSCAPE
3.5.2.2 ENVIRONMENTAL LANDSCAPE
3.5.2.3 SOCIAL LANDSCAPE
3.5.2.4 SERVICES LANDSCAPE
3.5.2.5 LEGAL LANDSCAPE
3.5.3 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS
3.5.3.1 JOINT VENTURES
3.5.3.2 MERGERS AND ACQUISITIONS
3.5.3.3 LICENSING AND PARTNERSHIP
3.5.3.4 SERVICES COLLABORATIONS
3.5.3.5 STRATEGIC DIVESTMENTS
CHAPTER 4 RESEARCH ANTIBODIES MARKET - COMPETITIVE ANALYSIS
4.1 RECENT DEVELOPMENTS & IMPACT ANALYSIS, BY KEY MARKET PARTICIPANTS
4.2 COMPANY CATEGORIZATION
4.2.1 LIST OF KEY DISTRIBUTORS AND CHANNEL PARTNERS
4.2.2 KEY COMPANY MARKET SHARE ANALYSIS, 2019
4.3 PUBLIC COMPANIES
4.3.1 COMPANY MARKET POSITION ANALYSIS
4.4 PRIVATE COMPANIES
4.4.1 LIST OF KEY EMERGING COMPANIES
4.4.2 REGIONAL NETWORK MAP
4.4.3 COMPANY MARKET POSITION ANALYSIS
CHAPTER 5 RESEARCH ANTIBODIES MARKET: PRODUCT ESTIMATES AND TREND ANALYSIS
5.1 DEFINITION & SCOPE
5.2 PRODUCT MARKET SHARE ANALYSIS, 2019 & 2027
5.3 SEGMENT DASHBOARD
5.4 GLOBAL RESEARCH ANTIBODIES MARKET, BY PRODUCT, 2016 TO 2027
5.5 MARKET SIZE & FORECASTS AND TREND ANALYSES, 2016 TO 2027
5.6 PRIMARY ANTIBODIES
5.6.1 PRIMARY ANTIBODIES MARKET ESTIMATES AND FORECASTS, 2016 TO 2027 (USD MILLION)
5.7 SECONDARY ANTIBODIES
5.7.1 SECONDARY ANTIBODIES MARKET ESTIMATES AND FORECASTS, 2016 TO 2027 (USD MILLION)
CHAPTER 6 RESEARCH ANTIBODIES MARKET: TYPE ESTIMATES AND TREND ANALYSIS
6.1 DEFINITION & SCOPE
6.2 TYPE MARKET SHARE ANALYSIS, 2019 & 2027
6.3 SEGMENT DASHBOARD
6.4 GLOBAL RESEARCH ANTIBODIES MARKET, BY TYPE, 2016 TO 2027
6.5 MARKET SIZE & FORECASTS AND TREND ANALYSES, 2016 TO 2027
6.6 MONOCLONAL ANTIBODIES
6.6.1 MONOCLONAL ANTIBODIES MARKET ESTIMATES AND FORECASTS, 2016 TO 2027 (USD MILLION)
6.7 POLYCLONAL ANTIBODIES
6.7.1 POLYCLONAL ANTIBODIES MARKET ESTIMATES AND FORECASTS, 2016 TO 2027 (USD MILLION)
CHAPTER 7 RESEARCH ANTIBODIES MARKET: TECHNOLOGY ESTIMATES AND TREND ANALYSIS
7.1 DEFINITION & SCOPE
7.2 TECHNOLOGY MARKET SHARE ANALYSIS, 2019 & 2027
7.3 SEGMENT DASHBOARD
7.4 GLOBAL RESEARCH ANTIBODIES MARKET, BY TECHNOLOGY, 2016 TO 2027
7.5 MARKET SIZE & FORECASTS AND TREND ANALYSES, 2016 TO 2027
7.6 IMMUNOCHEMISTRY
7.6.1 IMMUNOCHEMISTRY MARKET ESTIMATES AND FORECASTS, 2016 TO 2027 (USD MILLION)
7.7 IMMUNOFLUORESCENCE
7.7.1 IMMUNOFLUORESCENCE MARKET ESTIMATES AND FORECASTS, 2016 TO 2027 (USD MILLION)
7.8 WESTERN BLOTTING
7.8.1 WESTERN BLOTTING MARKET ESTIMATES AND FORECASTS, 2016 TO 2027 (USD MILLION)
7.9 FLOW CYTOMETRY
7.9.1 FLOW CYTOMETRY MARKET ESTIMATES AND FORECASTS, 2016 TO 2027 (USD MILLION)
7.10 IMMUNOPRECIPITATION
7.10.1 IMMUNOPRECIPITATION MARKET ESTIMATES AND FORECASTS, 2016 TO 2027 (USD MILLION)
7.11 ELISA
7. 11.1 ELISA MARKET ESTIMATES AND FORECASTS, 2016 TO 2027 (USD MILLION)
7.12 OTHER TECHNOLOGIES
7. 12.1OTHER TECHNOLOGIES MARKET ESTIMATES AND FORECASTS, 2016 TO 2027 (USD MILLION)
CHAPTER 8 RESEARCH ANTIBODIES MARKET: APPLICATION ESTIMATES AND TREND ANALYSIS
8.1 DEFINITION & SCOPE
8.2 APPLICATION MARKET SHARE ANALYSIS, 2019 & 2027
8.3 SEGMENT DASHBOARD
8.4 GLOBAL RESEARCH ANTIBODIES MARKET, BY APPLICATION, 2016 TO 2027
8.5 MARKET SIZE & FORECASTS AND TREND ANALYSES, 2016 TO 2027
8.6 INFECTIOUS DISEASES
8.6.1 INFECTIOUS DISEASES MARKET ESTIMATES AND FORECASTS, 2016 TO 2027 (USD MILLION)
8.7 IMMUNOLOGY
8.7.1 IMMUNOLOGY MARKET ESTIMATES AND FORECASTS, 2016 TO 2027 (USD MILLION)
8.8 ONCOLOGY
8.8.1 ONCOLOGY MARKET ESTIMATES AND FORECASTS, 2016 TO 2027 (USD MILLION)
8.9 STEM CELLS
8.9.1 STEM CELLS MARKET ESTIMATES AND FORECASTS, 2016 TO 2027 (USD MILLION)
8.10 NEUROBIOLOGY
8.10.1 NEUROBIOLOGY MARKET ESTIMATES AND FORECASTS, 2016 TO 2027 (USD MILLION)
8.11 OTHER APPLICATIONS
8.11.1 OTHER APPLICATIONS MARKET ESTIMATES AND FORECASTS, 2016 TO 2027 (USD MILLION)
CHAPTER 9 RESEARCH ANTIBODIES MARKET: SOURCE ESTIMATES AND TREND ANALYSIS
9.1 DEFINITION & SCOPE
9.2 SOURCE MARKET SHARE ANALYSIS, 2019 & 2027
9.3 SEGMENT DASHBOARD
9.4 GLOBAL RESEARCH ANTIBODIES MARKET, BY SOURCE, 2016 TO 2027
9.5 MARKET SIZE & FORECASTS AND TREND ANALYSES, 2016 TO 2027
9.6 MOUSE ANTIBODIES
9.6.1 MOUSE ANTIBODIES MARKET ESTIMATES AND FORECASTS, 2016 TO 2027 (USD MILLION)
9.7 RABBIT ANTIBODIES
9.7.1 RABBIT ANTIBODIES MARKET ESTIMATES AND FORECASTS, 2016 TO 2027 (USD MILLION)
9.8 GOAT ANTIBODIES
9.8.1 GOAT ANTIBODIES MARKET ESTIMATES AND FORECASTS, 2016 TO 2027 (USD MILLION)
9.9 OTHER SOURCES
9.9.1 OTHER SOURCS MARKET ESTIMATES AND FORECASTS, 2016 TO 2027 (USD MILLION)
CHAPTER 10 RESEARCH ANTIBODIES MARKET: END USE ESTIMATES AND TREND ANALYSIS
10.1 DEFINITION & SCOPE
10.2 END USE MARKET SHARE ANALYSIS, 2019 & 2027
10.3 SEGMENT DASHBOARD
10.4 GLOBAL RESEARCH ANTIBODIES MARKET, BY END USE, 2016 TO 2027
10.5 MARKET SIZE & FORECASTS AND TREND ANALYSES, 2016 TO 2027
10.6 ACADEMIC & RESEARCH INSTITUTES
10.6.1 ACADEMIC & RESEARCH INSTITUTES MARKET ESTIMATES AND FORECASTS, 2016 TO 2027 (USD MILLION)
10.7 CONTRACT RESEARCH ORGANIZATIONS
10.7.1 CONTRACT RESEARCH ORGANIZATIONS MARKET ESTIMATES AND FORECASTS, 2016 TO 2027 (USD MILLION)
10.8 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
10.8.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET ESTIMATES AND FORECASTS, 2016 TO 2027 (USD MILLION)
CHAPTER 11 RESEARCH ANTIBODIES MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
11.1 REGIONAL MARKET SNAPSHOT
11.2 MARKET SHARE ANALYSIS BY COUNTRY, 2019
11.2.1 NORTH AMERICA
11.2.1.1 U.S.
11.2.1.2 CANADA
11.2.2 EUROPE
11.2.2.1 U.K.
11.2.2.2 GERMANY
11.2.2.3 SPAIN
11.2.2.4 FRANCE
11.2.2.5 ITALY
11.2.2.6 RUSSIA
11.2.3 LATIN AMERICA
11.2.3.1 BRAZIL
11.2.3.2 MEXICO
11.2.3.3 ARGENTINA
11.2.4 ASIA PACIFIC
11.2.4.1 JAPAN
11.2.4.2 CHINA
11.2.4.3 INDIA
11.2.4.4 SOUTH KOREA
11.2.4.5 AUSTRALIA
11.2.4.6 SINGAPORE
11.2.5 MIDDLE EAST & AFRICA
11.2.5.1 SOUTH AFRICA
11.2.5.2 SAUDI ARABIA
11.2.5.3 UAE
11.3 SWOT ANALYSIS, BY FACTOR (POLITICAL & LEGAL, ECONOMIC AND TECHNOLOGICAL)
11.3.1 NORTH AMERICA
11.3.2 EUROPE
11.3.3 LATIN AMERICA
11.3.4 ASIA PACIFIC
11.3.5 MIDDLE EAST & AFRICA
11.4 MARKET SIZE & FORECASTS, AND TREND ANALYSIS, 2019 TO 2026
11.4.1 NORTH AMERICA
11.4.1.1 MARKET SIZE, & FORECASTS AND TREND ANALYSIS, 2016 TO 2027 (USD MILLION)
11.4.1.2 U.S.
11.4.1.2.1 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY PRODUCT, 2016 TO 2027 (USD MILLION)
11.4.1.2.2 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY TYPE, 2016 TO 2027 (USD MILLION)
11.4.1.2.3 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY TECHNOLOGY, 2016 TO 2027 (USD MILLION)
11.4.1.2.4 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY APPLICATION, 2016 TO 2027 (USD MILLION)
11.4.1.2.5 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY SOURCE, 2016 TO 2027 (USD MILLION)
11.4.1.2.6 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY END USE, 2016 TO 2027 (USD MILLION)
11.4.1.3 CANADA
11.4.1.3.1 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY PRODUCT, 2016 TO 2027 (USD MILLION)
11.4.1.3.2 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY TYPE, 2016 TO 2027 (USD MILLION)
11.4.1.3.3 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY TECHNOLOGY, 2016 TO 2027 (USD MILLION)
11.4.1.3.4 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY APPLICATION, 2016 TO 2027 (USD MILLION)
11.4.1.3.5 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY SOURCE, 2016 TO 2027 (USD MILLION)
11.4.1.3.6 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY END USE, 2016 TO 2027 (USD MILLION)
11.4.2 EUROPE
11.4.2.1 EUROPE MARKET SIZE, & FORECASTS AND TREND ANALYSIS, 2016 TO 2027 (USD MILLION)
11.4.2.2 U.K.
11.4.2.2.1 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY PRODUCT, 2016 TO 2027 (USD MILLION)
11.4.2.2.2 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY TYPE, 2016 TO 2027 (USD MILLION)
11.4.2.2.3 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY TECHNOLOGY, 2016 TO 2027 (USD MILLION)
11.4.2.2.4 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY APPLICATION, 2016 TO 2027 (USD MILLION)
11.4.2.2.5 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY SOURCE, 2016 TO 2027 (USD MILLION)
11.4.2.2.6 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY END USE, 2016 TO 2027 (USD MILLION)
11.4.2.3 GERMANY
11.4.2.3.1 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY PRODUCT, 2016 TO 2027 (USD MILLION)
11.4.2.3.2 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY TYPE, 2016 TO 2027 (USD MILLION)
11.4.2.3.3 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY TECHNOLOGY, 2016 TO 2027 (USD MILLION)
11.4.2.3.4 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY APPLICATION, 2016 TO 2027 (USD MILLION)
11.4.2.3.5 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY SOURCE, 2016 TO 2027 (USD MILLION)
11.4.2.3.6 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY END USE, 2016 TO 2027 (USD MILLION)
11.4.2.4 SPAIN
11.4.2.4.1 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY PRODUCT, 2016 TO 2027 (USD MILLION)
11.4.2.4.2 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY TYPE, 2016 TO 2027 (USD MILLION)
11.4.2.4.3 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY TCEHNOLOGY, 2016 TO 2027 (USD MILLION)
11.4.2.4.4 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY APPLICATION, 2016 TO 2027 (USD MILLION)
11.4.2.4.5 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY SOURCE, 2016 TO 2027 (USD MILLION)
11.4.2.4.6 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY END USE, 2016 TO 2027 (USD MILLION)
11.4.2.5 FRANCE
11.4.2.5.1 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY PRODUCT, 2016 TO 2027 (USD MILLION)
11.4.2.5.2 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY TYPE, 2016 TO 2027 (USD MILLION)
11.4.2.5.3 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY TECHNOLOGY, 2016 TO 2027 (USD MILLION)
11.4.2.5.4 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY APPLICATION, 2016 TO 2027 (USD MILLION)
11.4.2.5.5 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY SOURCE, 2016 TO 2027 (USD MILLION)
11.4.2.5.6 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY END USE, 2016 TO 2027 (USD MILLION)
11.4.2.6 ITALY
11.4.2.6.1 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY PRODUCT, 2016 TO 2027 (USD MILLION)
11.4.2.6.2 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY TYPE, 2016 TO 2027 (USD MILLION)
11.4.2.6.3 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY TECHNOLOGY, 2016 TO 2027 (USD MILLION)
11.4.2.6.4 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY APPLICATION, 2016 TO 2027 (USD MILLION)
11.4.2.6.5 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY SOURCE, 2016 TO 2027 (USD MILLION)
11.4.2.6.6 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY END USE, 2016 TO 2027 (USD MILLION)
11.4.2.7 RUSSIA
11.4.2.7.1 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY PRODUCT, 2016 TO 2027 (USD MILLION)
11.4.2.7.2 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY TYPE, 2016 TO 2027 (USD MILLION)
11.4.2.7.3 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY TECHNOLOGY, 2016 TO 2027 (USD MILLION)
11.4.2.7.4 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY APPLICATION, 2016 TO 2027 (USD MILLION)
11.4.2.7.5 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY SOURCE, 2016 TO 2027 (USD MILLION)
11.4.2.7.6 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY END USE, 2016 TO 2027 (USD MILLION)
11.4.3 ASIA PACIFIC
11.4.3.1 MARKET SIZE, & FORECASTS AND TREND ANALYSIS, 2016 TO 2027 (USD MILLION)
11.4.3.2 JAPAN
11.4.3.2.1 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY PRODUCT, 2016 TO 2027 (USD MILLION)
11.4.3.2.2 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY TYPE, 2016 TO 2027 (USD MILLION)
11.4.3.2.3 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY TECHNOLOGY, 2016 TO 2027 (USD MILLION)
11.4.3.2.4 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY APPLICATION, 2016 TO 2027 (USD MILLION)
11.4.3.2.5 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY SOURCE, 2016 TO 2027 (USD MILLION)
11.4.3.2.6 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY END USE, 2016 TO 2027 (USD MILLION)
11.4.3.3 CHINA
11.4.3.3.1 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY PRODUCT, 2016 TO 2027 (USD MILLION)
11.4.3.3.2 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY TYPE, 2016 TO 2027 (USD MILLION)
11.4.3.3.3 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY TECHNOLOGY, 2016 TO 2027 (USD MILLION)
11.4.3.3.4 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY APPLICATION, 2016 TO 2027 (USD MILLION)
11.4.3.3.5 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY SOURCE, 2016 TO 2027 (USD MILLION)
11.4.3.3.6 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY END USE, 2016 TO 2027 (USD MILLION)
11.4.3.4 INDIA
11.4.3.4.1 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY PRODUCT, 2016 TO 2027 (USD MILLION)
11.4.3.4.2 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY TYPE, 2016 TO 2027 (USD MILLION)
11.4.3.4.3 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY TECHNOLOGY, 2016 TO 2027 (USD MILLION)
11.4.3.4.4 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY APPLICATION, 2016 TO 2027 (USD MILLION)
11.4.3.4.5 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY SOURCE, 2016 TO 2027 (USD MILLION)
11.4.3.4.6 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY END USE, 2016 TO 2027 (USD MILLION)
11.4.3.5 SOUTH KOREA
11.4.3.5.1 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY PRODUCT, 2016 TO 2027 (USD MILLION)
11.4.3.5.2 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY TYPE, 2016 TO 2027 (USD MILLION)
11.4.3.5.3 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY TECHNOLOGY, 2016 TO 2027 (USD MILLION)
11.4.3.5.4 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY APPLICATION, 2016 TO 2027 (USD MILLION)
11.4.3.5.5 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY SOURCE, 2016 TO 2027 (USD MILLION)
11.4.3.5.6 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY END USE, 2016 TO 2027 (USD MILLION)
11.4.3.6 AUSTRALIA
11.4.3.6.1 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY PRODUCT, 2016 TO 2027 (USD MILLION)
11.4.3.6.2 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY TYPE, 2016 TO 2027 (USD MILLION)
11.4.3.6.3 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY TECHNOLOGY, 2016 TO 2027 (USD MILLION)
11.4.3.6.4 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY APPLICATION, 2016 TO 2027 (USD MILLION)
11.4.3.6.5 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY SOURCE, 2016 TO 2027 (USD MILLION)
11.4.3.6.6 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY END USE, 2016 TO 2027 (USD MILLION)
11.4.3.7 SINGAPORE
11.4.3.7.1 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY PRODUCT, 2016 TO 2027 (USD MILLION)
11.4.3.7.2 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY TYPE, 2016 TO 2027 (USD MILLION)
11.4.3.7.3 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY TECHNOLOGY, 2016 TO 2027 (USD MILLION)
11.4.3.7.4 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY APPLICATION, 2016 TO 2027 (USD MILLION)
11.4.3.7.5 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY SOURCE, 2016 TO 2027 (USD MILLION)
11.4.3.7.6 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY END USE, 2016 TO 2027 (USD MILLION)
11.4.4 LATIN AMERICA
11.4.4.1 MARKET SIZE, & FORECASTS AND TREND ANALYSIS, 2016 TO 2027 (USD MILLION)
11.4.4.2 BRAZIL
11.4.4.2.1 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY PRODUCT, 2016 TO 2027 (USD MILLION)
11.4.4.2.2 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY TYPE, 2016 TO 2027 (USD MILLION)
11.4.4.2.3 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY TECHNOLOGY, 2016 TO 2027 (USD MILLION)
11.4.4.2.4 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY APPLICATION, 2016 TO 2027 (USD MILLION)
11.4.4.2.5 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY SOURCE, 2016 TO 2027 (USD MILLION)
11.4.4.2.6 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY END USE, 2016 TO 2027 (USD MILLION)
11.4.4.3 MEXICO
11.4.4.3.1 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY PRODUCT, 2016 TO 2027 (USD MILLION)
11.4.4.3.2 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY TYPE, 2016 TO 2027 (USD MILLION)
11.4.4.3.3 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY TECHNOLOGY, 2016 TO 2027 (USD MILLION)
11.4.4.3.4 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY APPLICATION, 2016 TO 2027 (USD MILLION)
11.4.4.3.5 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY SOURCE, 2016 TO 2027 (USD MILLION)
11.4.4.3.6 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY END USE, 2016 TO 2027 (USD MILLION)
11.4.4.4 ARGENTINA
11.4.4.4.1 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY PRODUCT, 2016 TO 2027 (USD MILLION)
11.4.4.4.2 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY TYPE, 2016 TO 2027 (USD MILLION)
11.4.4.4.3 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY TECHNOLOGY, 2016 TO 2027 (USD MILLION)
11.4.4.4.4 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY APPLICATION, 2016 TO 2027 (USD MILLION)
11.4.4.4.5 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY SOURCE, 2016 TO 2027 (USD MILLION)
11.4.4.4.6 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY END USE, 2016 TO 2027 (USD MILLION)
11.4.5 MIDDLE EAST & AFRICA
11.4.5.1 MARKET SIZE, & FORECASTS AND TREND ANALYSIS, 2016 TO 2027 (USD MILLION)
11.4.5.2 SOUTH AFRICA
11.4.5.2.1 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY PRODUCT, 2016 TO 2027 (USD MILLION)
11.4.5.2.2 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY TYPE, 2016 TO 2027 (USD MILLION)
11.4.5.2.3 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY TECHNOLOGY, 2016 TO 2027 (USD MILLION)
11.4.5.2.4 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY APPLICATION, 2016 TO 2027 (USD MILLION)
11.4.5.2.5 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY SOURCE, 2016 TO 2027 (USD MILLION)
11.4.5.2.6 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY END USE, 2016 TO 2027 (USD MILLION)
11.4.5.3 SAUDI ARABIA
11.4.5.3.1 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY PRODUCT, 2016 TO 2027 (USD MILLION)
11.4.5.3.2 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY TYPE, 2016 TO 2027 (USD MILLION)
11.4.5.3.3 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY TECHNOLOGY, 2016 TO 2027 (USD MILLION)
11.4.5.3.4 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY APPLICATION, 2016 TO 2027 (USD MILLION)
11.4.5.3.5 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY SOURCE, 2016 TO 2027 (USD MILLION)
11.4.5.3.6 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY END USE, 2016 TO 2027 (USD MILLION)
11.4.5.4 UAE
11.4.5.4.1 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY PRODUCT, 2016 TO 2027 (USD MILLION)
11.4.5.4.2 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY TYPE, 2016 TO 2027 (USD MILLION)
11.4.5.4.3 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY TECHNOLOGY, 2016 TO 2027 (USD MILLION)
11.4.5.4.4 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY APPLICATION, 2016 TO 2027 (USD MILLION)
11.4.5.4.5 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY SOURCE, 2016 TO 2027 (USD MILLION)
11.4.5.4.6 MARKET SIZE & FORECASTS AND TREND ANALYSIS, BY END USE, 2016 TO 2027 (USD MILLION)
CHAPTER 12 COMPANY PROFILES
12.1 COMPANY PROFILES
12.1.1 ABCAM PLC
12.1.1.1 COMPANY OVERVIEW
12.1.1.2 FINANCIAL PERFORMANCE
12.1.1.3 PRODUCT BENCHMARKING
12.1.1.4 STRATEGIC INITIATIVES
12.1.2 BIO - RAD LABORATORIES
12.1.2.1 COMPANY OVERVIEW
12.1.2.2 FINANCIAL PERFORMANCE
12.1.2.3 PRODUCT BENCHMARKING
12.1.2.4 STRATEGIC INITIATIVES
12.1.3 BD
12.1.3.1 COMPANY OVERVIEW
12.1.3.2 FINANCIAL PERFORMANCE
12.1.3.3 PRODUCT BENCHMARKING
12.1.3.4 STRATEGIC INITIATIVES
12.1.4 MERCK MILLIPORE
12.1.4.1 COMPANY OVERVIEW
12.1.4.2 FINANCIAL PERFORMANCE
12.1.4.3 PRODUCT BENCHMARKING
12.1.4.4 STRATEGIC INITIATIVES
12.1.5 LONZA GROUP
12.1.5.1 COMPANY OVERVIEW
12.1.5.2 FINANCIAL PERFORMANCE
12.1.5.3 PRODUCT BENCHMARKING
12.1.5.4 STRATEGIC INITIATIVES
12.1.6 THERMO FISHER SCIENTIFIC
12.1.6.1 COMPANY OVERVIEW
12.1.6.2 FINANCIAL PERFORMANCE
12.1.6.3 PRODUCT BENCHMARKING
12.1.6.4 STRATEGIC INITIATIVES
12.1.7 CELL SIGNALLING TECHNOLOGY, INC.
12.1.7.1 COMPANY OVERVIEW
12.1.7.2 FINANCIAL PERFORMANCE
12.1.7.3 PRODUCT BENCHMARKING
12.1.7.4 STRATEGIC INITIATIVES
12.1.8 F.HOFFMANN LA ROCHE LTD.
12.1.8.1 COMPANY OVERVIEW
12.1.8.2 FINANCIAL PERFORMANCE
12.1.8.3 PRODUCT BENCHMARKING
12.1.8.4 STRATEGIC INITIATIVES
12.1.9 AGILENT TECHNOLOGIES
12.1.9.1 COMPANY OVERVIEW
12.1.9.2 FINANCIAL PERFORMANCE
12.1.9.3 PRODUCT BENCHMARKING
12.1.9.4 STRATEGIC INITIATIVES
12.1.10 PERKINELMER, INC.
12.1.10.1 COMPANY OVERVIEW
12.1.10.2 FINANCIAL PERFORMANCE
12.1.10.3 PRODUCT BENCHMARKING
12.1.10.4 STRATEGIC INITIATIVES
LIST OF TABLES
TABLE 1 LIST OF KEY DISTRIBUTORS AND CHANNEL PARTNERS
TABLE 2 LIST OF KEY EMERGING COMPANIES’/PRODUCT DISRUPTORS/INNOVATORS
TABLE 3 NORTH AMERICA RESEARCH ANTIBODIES MARKET, BY COUNTRIES, 2016 - 2027 (USD MILLION)
TABLE 4 NORTH AMERICA RESEARCH ANTIBODIES MARKET, BY PRODUCT, 2016 - 2027 (USD MILLION)
TABLE 5 NORTH AMERICA RESEARCH ANTIBODIES MARKET, BY TYPE, 2016 - 2027 (USD MILLION)
TABLE 6 NORTH AMERICA RESEARCH ANTIBODIES MARKET, BY TECHNOLOGY, 2016 - 2027 (USD MILLION)
TABLE 7 NORTH AMERICA RESEARCH ANTIBODIES MARKET, BY APPLICATION, 2016 - 2027 (USD MILLION)
TABLE 8 NORTH AMERICA RESEARCH ANTIBODIES MARKET, BY SOURCE, 2016 - 2027 (USD MILLION)
TABLE 9 NORTH AMERICA RESEARCH ANTIBODIES MARKET, BY END USE, 2016 - 2027 (USD MILLION)
TABLE 10 U.S. RESEARCH ANTIBODIES MARKET, BY PRODUCT, 2016 - 2027 (USD MILLION)
TABLE 11 U.S. RESEARCH ANTIBODIES MARKET, BY TYPE, 2016 - 2027 (USD MILLION)
TABLE 12 U.S. RESEARCH ANTIBODIES MARKET, BY TECHNOLOGY, 2016 - 2027 (USD MILLION)
TABLE 13 U.S. RESEARCH ANTIBODIES MARKET, BY APPLICATION, 2016 - 2027 (USD MILLION)
TABLE 14 U.S. RESEARCH ANTIBODIES MARKET, BY SOURCE, 2016 - 2027 (USD MILLION)
TABLE 15 U.S. RESEARCH ANTIBODIES MARKET, BY END USE, 2016 - 2027 (USD MILLION)
TABLE 16 CANADA RESEARCH ANTIBODIES MARKET, BY PRODUCT, 2016 - 2027 (USD MILLION)
TABLE 17 CANADA RESEARCH ANTIBODIES MARKET, BY TYPE, 2016 - 2027 (USD MILLION)
TABLE 18 CANADA RESEARCH ANTIBODIES MARKET, BY TECHNOLOGY, 2016 - 2027 (USD MILLION)
TABLE 19 CANADA RESEARCH ANTIBODIES MARKET, BY APPLICATION, 2016 - 2027 (USD MILLION)
TABLE 20 CANADA RESEARCH ANTIBODIES MARKET, BY SOURCE, 2016 - 2027 (USD MILLION)
TABLE 21 CANADA RESEARCH ANTIBODIES MARKET, BY END USE, 2016 - 2027 (USD MILLION)
TABLE 22 EUROPE RESEARCH ANTIBODIES MARKET, BY PRODUCT, 2016 - 2027 (USD MILLION)
TABLE 23 EUROPE RESEARCH ANTIBODIES MARKET, BY TYPE, 2016 - 2027 (USD MILLION)
TABLE 24 EUROPE RESEARCH ANTIBODIES MARKET, BY TECHNOLOGY, 2016 - 2027 (USD MILLION)
TABLE 25 EUROPE RESEARCH ANTIBODIES MARKET, BY APPLICATION, 2016 - 2027 (USD MILLION)
TABLE 26 EUROPE RESEARCH ANTIBODIES MARKET, BY SOURCE, 2016 - 2027 (USD MILLION)
TABLE 27 EUROPE RESEARCH ANTIBODIES MARKET, BY END USE, 2016 - 2027 (USD MILLION)
TABLE 28 U.K. RESEARCH ANTIBODIES MARKET, BY PRODUCT, 2016 - 2027 (USD MILLION)
TABLE 29 U.K. RESEARCH ANTIBODIES MARKET, BY TYPE, 2016 - 2027 (USD MILLION)
TABLE 30 U.K. RESEARCH ANTIBODIES MARKET, BY TECHNOLOGY, 2016 - 2027 (USD MILLION)
TABLE 31 U.K. RESEARCH ANTIBODIES MARKET, BY APPLICATION, 2016 - 2027 (USD MILLION)
TABLE 32 U.K. RESEARCH ANTIBODIES MARKET, BY SOURCE, 2016 - 2027 (USD MILLION)
TABLE 33 U.K. RESEARCH ANTIBODIES MARKET, BY END USE, 2016 - 2027 (USD MILLION)
TABLE 34 GERMANY RESEARCH ANTIBODIES MARKET, BY PRODUCT, 2016 - 2027 (USD MILLION)
TABLE 35 GERMANY RESEARCH ANTIBODIES MARKET, BY TYPE, 2016 - 2027 (USD MILLION)
TABLE 36 GERMANY RESEARCH ANTIBODIES MARKET, BY TECHNOLOGY, 2016 - 2027 (USD MILLION)
TABLE 37 GERMANY RESEARCH ANTIBODIES MARKET, BY APPLICATION, 2016 - 2027 (USD MILLION)
TABLE 38 GERMANY RESEARCH ANTIBODIES MARKET, BY SOURCE, 2016 - 2027 (USD MILLION)
TABLE 39 GERMANY RESEARCH ANTIBODIES MARKET, BY END USE, 2016 - 2027 (USD MILLION)
TABLE 40 FRANCE RESEARCH ANTIBODIES MARKET, BY PRODUCT, 2016 - 2027 (USD MILLION)
TABLE 41 FRANCE RESEARCH ANTIBODIES MARKET, BY TYPE, 2016 - 2027 (USD MILLION)
TABLE 42 FRANCE RESEARCH ANTIBODIES MARKET, BY TECHNOLOGY, 2016 - 2027 (USD MILLION)
TABLE 43 FRANCE RESEARCH ANTIBODIES MARKET, BY APPLICATION, 2016 - 2027 (USD MILLION)
TABLE 44 FRANCE RESEARCH ANTIBODIES MARKET, BY SOURCE, 2016 - 2027 (USD MILLION)
TABLE 45 FRANCE RESEARCH ANTIBODIES MARKET, BY END USE, 2016 - 2027 (USD MILLION)
TABLE 46 ITALY RESEARCH ANTIBODIES MARKET, BY PRODUCT, 2016 - 2027 (USD MILLION)
TABLE 47 ITALY RESEARCH ANTIBODIES MARKET, BY TYPE, 2016 - 2027 (USD MILLION)
TABLE 48 ITALY RESEARCH ANTIBODIES MARKET, BY TECHNOLOGY, 2016 - 2027 (USD MILLION)
TABLE 49 ITALY RESEARCH ANTIBODIES MARKET, BY APPLICATION, 2016 - 2027 (USD MILLION)
TABLE 50 ITALY RESEARCH ANTIBODIES MARKET, BY SOURCE, 2016 - 2027 (USD MILLION)
TABLE 51 ITALY RESEARCH ANTIBODIES MARKET, BY END USE, 2016 - 2027 (USD MILLION)
TABLE 52 SPAIN RESEARCH ANTIBODIES MARKET, BY PRODUCT, 2016 - 2027 (USD MILLION)
TABLE 53 SPAIN RESEARCH ANTIBODIES MARKET, BY TYPE, 2016 - 2027 (USD MILLION)
TABLE 54 SPAIN RESEARCH ANTIBODIES MARKET, BY TECHNOLOGY, 2016 - 2027 (USD MILLION)
TABLE 55 SPAIN RESEARCH ANTIBODIES MARKET, BY APPLICATION, 2016 - 2027 (USD MILLION)
TABLE 56 SPAIN RESEARCH ANTIBODIES MARKET, BY SOURCE, 2016 - 2027 (USD MILLION)
TABLE 57 SPAIN RESEARCH ANTIBODIES MARKET, BY END USE, 2016 - 2027 (USD MILLION)
TABLE 58 RUSSIA RESEARCH ANTIBODIES MARKET, BY PRODUCT, 2016 - 2027 (USD MILLION)
TABLE 59 RUSSIA RESEARCH ANTIBODIES MARKET, BY TYPE, 2016 - 2027 (USD MILLION)
TABLE 60 RUSSIA RESEARCH ANTIBODIES MARKET, BY TECHNOLOGY, 2016 - 2027 (USD MILLION)
TABLE 61 RUSSIA RESEARCH ANTIBODIES MARKET, BY APPLICATION, 2016 - 2027 (USD MILLION)
TABLE 62 RUSSIA RESEARCH ANTIBODIES MARKET, BY SOURCE, 2016 - 2027 (USD MILLION)
TABLE 63 RUSSIA RESEARCH ANTIBODIES MARKET, BY END USE, 2016 - 2027 (USD MILLION)
TABLE 64 ASIA PACIFIC RESEARCH ANTIBODIES MARKET, BY PRODUCT, 2016 - 2027 (USD MILLION)
TABLE 65 ASIA PACIFIC RESEARCH ANTIBODIES MARKET, BY TYPE, 2016 - 2027 (USD MILLION)
TABLE 66 ASIA PACIFIC RESEARCH ANTIBODIES MARKET, BY TECHNOLOGY, 2016 - 2027 (USD MILLION)
TABLE 67 ASIA PACIFIC RESEARCH ANTIBODIES MARKET, BY APPLICATION, 2016 - 2027 (USD MILLION)
TABLE 68 ASIA PACIFIC RESEARCH ANTIBODIES MARKET, BY SOURCE, 2016 - 2027 (USD MILLION)
TABLE 69 ASIA PACIFIC RESEARCH ANTIBODIES MARKET, BY END USE, 2016 - 2027 (USD MILLION)
TABLE 70 JAPAN RESEARCH ANTIBODIES MARKET, BY PRODUCT, 2016 - 2027 (USD MILLION)
TABLE 71 JAPAN RESEARCH ANTIBODIES MARKET, BY TYPE, 2016 - 2027 (USD MILLION)
TABLE 72 JAPAN RESEARCH ANTIBODIES MARKET, BY TECHNOLOGY, 2016 - 2027 (USD MILLION)
TABLE 73 JAPAN RESEARCH ANTIBODIES MARKET, BY APPLICATION, 2016 - 2027 (USD MILLION)
TABLE 74 JAPAN RESEARCH ANTIBODIES MARKET, BY SOURCE, 2016 - 2027 (USD MILLION)
TABLE 75 JAPAN RESEARCH ANTIBODIES MARKET, BY END USE, 2016 - 2027 (USD MILLION)
TABLE 76 CHINA RESEARCH ANTIBODIES MARKET, BY PRODUCT, 2016 - 2027 (USD MILLION)
TABLE 77 CHINA RESEARCH ANTIBODIES MARKET, BY TYPE, 2016 - 2027 (USD MILLION)
TABLE 78 CHINA RESEARCH ANTIBODIES MARKET, BY TECHNOLOGY, 2016 - 2027 (USD MILLION)
TABLE 79 CHINA RESEARCH ANTIBODIES MARKET, BY APPLICATION, 2016 - 2027 (USD MILLION)
TABLE 80 CHINA RESEARCH ANTIBODIES MARKET, BY SOURCE, 2016 - 2027 (USD MILLION)
TABLE 81 CHINA RESEARCH ANTIBODIES MARKET, BY END USE, 2016 - 2027 (USD MILLION)
TABLE 82 INDIA RESEARCH ANTIBODIES MARKET, BY PRODUCT, 2016 - 2027 (USD MILLION)
TABLE 83 INDIA RESEARCH ANTIBODIES MARKET, BY TYPE, 2016 - 2027 (USD MILLION)
TABLE 84 INDIA RESEARCH ANTIBODIES MARKET, BY TECHNOLOGY, 2016 - 2027 (USD MILLION)
TABLE 85 INDIA RESEARCH ANTIBODIES MARKET, BY APPLICATION, 2016 - 2027 (USD MILLION)
TABLE 86 INDIA RESEARCH ANTIBODIES MARKET, BY SOURCE, 2016 - 2027 (USD MILLION)
TABLE 87 INDIA RESEARCH ANTIBODIES MARKET, BY END USE, 2016 - 2027 (USD MILLION)
TABLE 88 SOUTH KOREA RESEARCH ANTIBODIES MARKET, BY PRODUCT, 2016 - 2027 (USD MILLION)
TABLE 89 SOUTH KOREA RESEARCH ANTIBODIES MARKET, BY TYPE, 2016 - 2027 (USD MILLION)
TABLE 90 SOUTH KOREA RESEARCH ANTIBODIES MARKET, BY TECHNOLOGY, 2016 - 2027 (USD MILLION)
TABLE 91 SOUTH KOREA RESEARCH ANTIBODIES MARKET, BY APPLICATION, 2016 - 2027 (USD MILLION)
TABLE 92 SOUTH KOREA RESEARCH ANTIBODIES MARKET, BY SOURCE, 2016 - 2027 (USD MILLION)
TABLE 93 SOUTH KOREA RESEARCH ANTIBODIES MARKET, BY END USE, 2016 - 2027 (USD MILLION)
TABLE 94 AUSTRALIA RESEARCH ANTIBODIES MARKET, BY PRODUCT, 2016 - 2027 (USD MILLION)
TABLE 95 AUSTRALIA RESEARCH ANTIBODIES MARKET, BY TYPE, 2016 - 2027 (USD MILLION)
TABLE 96 AUSTRALIA RESEARCH ANTIBODIES MARKET, BY TECHNOLOGY, 2016 - 2027 (USD MILLION)
TABLE 97 AUSTRALIA RESEARCH ANTIBODIES MARKET, BY APPLICATION, 2016 - 2027 (USD MILLION)
TABLE 98 AUSTRALIA RESEARCH ANTIBODIES MARKET, BY SOURCE, 2016 - 2027 (USD MILLION)
TABLE 99 AUSTRALIA RESEARCH ANTIBODIES MARKET, BY END USE, 2016 - 2027 (USD MILLION)
TABLE 100 LATIN AMERICA RESEARCH ANTIBODIES MARKET, BY PRODUCT, 2016 - 2027 (USD MILLION)
TABLE 101 LATIN AMERICA RESEARCH ANTIBODIES MARKET, BY TYPE, 2016 - 2027 (USD MILLION)
TABLE 102 LATIN AMERICA RESEARCH ANTIBODIES MARKET, BY TECHNOLOGY, 2016 - 2027 (USD MILLION)
TABLE 103 LATIN AMERICA RESEARCH ANTIBODIES MARKET, BY APPLICATION, 2016 - 2027 (USD MILLION)
TABLE 104 LATIN AMERICA RESEARCH ANTIBODIES MARKET, BY SOURCE, 2016 - 2027 (USD MILLION)
TABLE 105 LATIN AMERICA RESEARCH ANTIBODIES MARKET, BY END USE, 2016 - 2027 (USD MILLION)
TABLE 106 BRAZIL RESEARCH ANTIBODIES MARKET, BY PRODUCT, 2016 - 2027 (USD MILLION)
TABLE 107 BRAZIL RESEARCH ANTIBODIES MARKET, BY TYPE, 2016 - 2027 (USD MILLION)
TABLE 108 BRAZIL RESEARCH ANTIBODIES MARKET, BY TECHNOLOGY, 2016 - 2027 (USD MILLION)
TABLE 109 BRAZIL RESEARCH ANTIBODIES MARKET, BY APPLICATION, 2016 - 2027 (USD MILLION)
TABLE 110 BRAZIL RESEARCH ANTIBODIES MARKET, BY SOURCE, 2016 - 2027 (USD MILLION)
TABLE 111 BRAZIL RESEARCH ANTIBODIES MARKET, BY END USE, 2016 - 2027 (USD MILLION)
TABLE 112 MEXICO RESEARCH ANTIBODIES MARKET, BY PRODUCT, 2016 - 2027 (USD MILLION)
TABLE 113 MEXICO RESEARCH ANTIBODIES MARKET, BY TYPE, 2016 - 2027 (USD MILLION)
TABLE 114 MEXICO RESEARCH ANTIBODIES MARKET, BY TECHNOLOGY, 2016 - 2027 (USD MILLION)
TABLE 115 MEXICO RESEARCH ANTIBODIES MARKET, BY APPLICATION, 2016 - 2027 (USD MILLION)
TABLE 116 MEXICO RESEARCH ANTIBODIES MARKET, BY SOURCE, 2016 - 2027 (USD MILLION)
TABLE 117 MEXICO RESEARCH ANTIBODIES MARKET, BY END USE, 2016 - 2027 (USD MILLION)
TABLE 118 ARGENTINA RESEARCH ANTIBODIES MARKET, BY PRODUCT, 2016 - 2027 (USD MILLION)
TABLE 119 ARGENTINA RESEARCH ANTIBODIES MARKET, BY TYPE, 2016 - 2027 (USD MILLION)
TABLE 120 ARGENTINA RESEARCH ANTIBODIES MARKET, BY TECHNOLOGY, 2016 - 2027 (USD MILLION)
TABLE 121 ARGENTINA RESEARCH ANTIBODIES MARKET, BY APPLICATION, 2016 - 2027 (USD MILLION)
TABLE 122 ARGENTINA RESEARCH ANTIBODIES MARKET, BY SOURCE, 2016 - 2027 (USD MILLION)
TABLE 123 ARGENTINA RESEARCH ANTIBODIES MARKET, BY END USE, 2016 - 2027 (USD MILLION)
TABLE 124 MEA RESEARCH ANTIBODIES MARKET, BY PRODUCT, 2016 - 2027 (USD MILLION)
TABLE 125 MEA RESEARCH ANTIBODIES MARKET, BY TYPE, 2016 - 2027 (USD MILLION)
TABLE 126 MEA RESEARCH ANTIBODIES MARKET, BY TECHNOLOGY, 2016 - 2027 (USD MILLION)
TABLE 127 MEA RESEARCH ANTIBODIES MARKET, BY APPLICATION, 2016 - 2027 (USD MILLION)
TABLE 128 MEA RESEARCH ANTIBODIES MARKET, BY SOURCE, 2016 - 2027 (USD MILLION)
TABLE 129 MEA RESEARCH ANTIBODIES MARKET, BY END USE, 2016 - 2027 (USD MILLION)
TABLE 130 SOUTH AFRICA RESEARCH ANTIBODIES MARKET, BY PRODUCT, 2016 - 2027 (USD MILLION)
TABLE 131 SOUTH AFRICA RESEARCH ANTIBODIES MARKET, BY TYPE, 2016 - 2027 (USD MILLION)
TABLE 132 SOUTH AFRICA RESEARCH ANTIBODIES MARKET, BY TECHNOLOGY, 2016 - 2027 (USD MILLION)
TABLE 133 SOUTH AFRICA RESEARCH ANTIBODIES MARKET, BY APPLICATION, 2016 - 2027 (USD MILLION)
TABLE 134 SOUTH AFRICA RESEARCH ANTIBODIES MARKET, BY SOURCE, 2016 - 2027 (USD MILLION)
TABLE 135 SOUTH AFRICA RESEARCH ANTIBODIES MARKET, BY END USE, 2016 - 2027 (USD MILLION)
TABLE 136 SAUDI ARABIA RESEARCH ANTIBODIES MARKET, BY PRODUCT, 2016 - 2027 (USD MILLION)
TABLE 137 SAUDI ARABIA RESEARCH ANTIBODIES MARKET, BY TYPE, 2016 - 2027 (USD MILLION)
TABLE 138 SAUDI ARABIA RESEARCH ANTIBODIES MARKET, BY TECHNOLOGY, 2016 - 2027 (USD MILLION)
TABLE 139 SAUDI ARABIA RESEARCH ANTIBODIES MARKET, BY APPLICATION, 2016 - 2027 (USD MILLION)
TABLE 140 SAUDI ARABIA RESEARCH ANTIBODIES MARKET, BY SOURCE, 2016 - 2027 (USD MILLION)
TABLE 141 SAUDI ARABIA RESEARCH ANTIBODIES MARKET, BY END USE, 2016 - 2027 (USD MILLION)
TABLE 142 UAE RESEARCH ANTIBODIES MARKET, BY PRODUCT, 2016 - 2027 (USD MILLION)
TABLE 143 UAE RESEARCH ANTIBODIES MARKET, BY TYPE, 2016 - 2027 (USD MILLION)
TABLE 144 UAE RESEARCH ANTIBODIES MARKET, BY TECHNOLOGY, 2016 - 2027 (USD MILLION)
TABLE 145 UAE RESEARCH ANTIBODIES MARKET, BY APPLICATION, 2016 - 2027 (USD MILLION)
TABLE 146 UAE RESEARCH ANTIBODIES MARKET, BY SOURCE, 2016 - 2027 (USD MILLION)
TABLE 147 UAE RESEARCH ANTIBODIES MARKET, BY END USE, 2016 - 2027 (USD MILLION)
LIST OF FIGURES
FIG. 1 RESEARCH ANTIBODIES MARKET SEGMENTATION
FIG. 2 MARKET RESEARCH PROCESS
FIG. 3 INFORMATION PROCUREMENT
FIG. 4 PRIMARY RESEARCH PATTERN
FIG. 5 MARKET RESEARCH APPROACHES
FIG. 6 VALUE CHAIN BASED SIZING & FORECASTING
FIG. 7 RESEARCH ANTIBODIES MARKET SNAPSHOT (2019)
FIG. 8 RESEARCH ANTIBODIES MARKET: SEGMENT SNAPSHOT (2019)
FIG. 9 COMPETITIVE INSIGHTS (2019)
FIG. 10 PARENT MARKET OUTLOOK
FIG. 11 RELATED/ANCILLARY MARKET OUTLOOK
FIG. 12 PENETRATION AND GROWTH PROSPECT MAPPING
FIG. 13 INDUSTRY VALUE CHAIN ANALYSIS
FIG. 14 RESEARCH ANTIBODIES MARKET DRIVER IMPACT
FIG. 15 RESEARCH ANTIBODIES MARKET RESTRAINT IMPACT
FIG. 16 RESEARCH ANTIBODIES MARKET OPPORTUNITIES IMPACT
FIG. 17 RESEARCH ANTIBODIES MARKET CHALLENGES IMPACT
FIG. 18 PORTER’S FIVE FORCES ANALYSIS
FIG. 19 SWOT ANALYSIS, BY FACTOR (POLITICAL & LEGAL ECONOMIC AND TECHNOLOGICAL)
FIG. 20 STRATEGIC ALLIANCE ANALYSIS
FIG. 21 RECENT DEVELOPMENTS & IMPACT ANALYSIS, BY KEY MARKET PARTICIPANTS
FIG. 22 KEY COMPANY MARKET SHARE ANALYSIS, 2019
FIG. 23 COMPANY MARKET SHARE/RANKING, BY REGION
FIG. 24 COMPANY MARKET POSITION ANALYSIS
FIG. 25 DEFINITION AND SCOPE, BY DISEASE TECHNOLOGY
FIG. 26 PRODUCT MARKET SHARE ANALYSIS, 2019 & 2027
FIG. 27 SEGMENT DASHBOARD
FIG. 28 GLOBAL RESEARCH ANTIBODIES MARKET, BY PRODUCT, 2016 - 2027 (USD MILLION)
FIG. 29 GLOBAL PRIMARY ANTIBODIES MARKET, 2016 - 2027 (USD MILLION)
FIG. 30 GLOBAL SECONDARY ANTIBODIES MARKET, 2016 - 2027 (USD MILLION)
FIG. 31 GLOBAL RESEARCH ANTIBODIES MARKET, BY TYPE, 2016 - 2027 (USD MILLION)
FIG. 32 GLOBAL MONOCLONAL ANTIBODIES MARKET, 2016 - 2027 (USD MILLION)
FIG. 33 GLOBAL POLYCLONAL ANTIBODIES MARKET, 2016 - 2027 (USD MILLION)
FIG. 34 GLOBAL RESEARCH ANTIBODIES MARKET, BY TECHNOLOGY, 2016 - 2027 (USD MILLION)
FIG. 35 GLOBAL IMMUNOCHEMISTRY MARKET, 2016 - 2027 (USD MILLION)
FIG. 36 GLOBAL IMMUNOFLUORESCENCE MARKET, 2016 - 2027 (USD MILLION)
FIG. 37 GLOBAL WESTERN BLOTTING MARKET, 2016 - 2027 (USD MILLION)
FIG. 38 GLOBAL FLOW CYTOMETRY MARKET, 2016 - 2027 (USD MILLION)
FIG. 39 GLOBAL IMMUNOPRECIPITATION MARKET, 2016 - 2027 (USD MILLION)
FIG. 40 GLOBAL OTHER TECHNOLOGIES MARKET, 2016 - 2027 (USD MILLION)
FIG. 41 GLOBAL RESEARCH ANTIBODIES MARKET, BY APPLICATION, 2016 - 2027 (USD MILLION)
FIG. 42 GLOBAL INFECTIOUS DISEASES MARKET, 2016 - 2027 (USD MILLION)
FIG. 43 GLOBAL IMMUNOLOGY MARKET, 2016 - 2027 (USD MILLION)
FIG. 44 GLOBAL ONCOLOGY MARKET, 2016 - 2027 (USD MILLION)
FIG. 45 GLOBAL STEM CELLS MARKET, 2016 - 2027 (USD MILLION)
FIG. 46 GLOBAL NEUROBIOLOGY MARKET, 2016 - 2027 (USD MILLION)
FIG. 47 GLOBAL OTHER APPLICATIONS MARKET, 2016 - 2027 (USD MILLION)
FIG. 48 GLOBAL RESEARCH ANTIBODIES MARKET, BY SOURCE, 2016 - 2027 (USD MILLION)
FIG. 49 GLOBAL MOUSE ANTIBODIES MARKET, 2016 - 2027 (USD MILLION)
FIG. 50 GLOBAL RABBIT ANTIBODIES MARKET, 2016 - 2027 (USD MILLION)
FIG. 51 GLOBAL GOAT ANTIBODIES MARKET, 2016 - 2027 (USD MILLION)
FIG. 52 GLOBAL OTHER SOURCES MARKET, 2016 - 2027 (USD MILLION)
FIG. 53 GLOBAL RESEARCH ANTIBODIES MARKET, BY END USE, 2016 - 2027 (USD MILLION)
FIG. 54 GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET, 2016 - 2027 (USD MILLION)
FIG. 55 GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET, 2016 - 2027 (USD MILLION)
FIG. 56 GLOBAL OTHER END USERS MARKET, 2016 - 2027 (USD MILLION)
FIG. 57 RESEARCH ANTIBODIES MARKET SNAPSHOT
FIG. 58 NORTH AMERICA RESEARCH ANTIBODIES MARKET SHARE ANALYSIS BY COUNTRY, 2019
FIG. 59 EUROPE RESEARCH ANTIBODIES MARKET SHARE ANALYSIS BY COUNTRY, 2019
FIG. 60 ASIA PACIFIC RESEARCH ANTIBODIES MARKET SHARE ANALYSIS BY COUNTRY, 2019
FIG. 61 LATIN AMERICA RESEARCH ANTIBODIES MARKET SHARE ANALYSIS BY COUNTRY, 2019
FIG. 62 MIDDLE EAST AND AFRICA RESEARCH ANTIBODIES MARKET SHARE ANALYSIS BY COUNTRY, 2019
FIG. 63 NORTH AMERICA SWOT ANALYSIS, BY FACTOR (POLITICAL & LEGAL, ECONOMIC AND TECHNOLOGICAL)
FIG. 64 EUROPE SWOT ANALYSIS, BY FACTOR (POLITICAL & LEGAL, ECONOMIC AND TECHNOLOGICAL)
FIG. 65 ASIA PACIFIC SWOT ANALYSIS, BY FACTOR (POLITICAL & LEGAL, ECONOMIC AND TECHNOLOGICAL)
FIG. 66 LATIN AMERICA SWOT ANALYSIS, BY FACTOR (POLITICAL & LEGAL, ECONOMIC AND TECHNOLOGICAL)
FIG. 67 MIDDLE EAST AND AFRICA SWOT ANALYSIS, BY FACTOR (POLITICAL & LEGAL, ECONOMIC AND TECHNOLOGICAL)
掲載企業リスト
プレスリリース
プレスリリース
当レポートのプレスリリースは発行されておりません。
リサーチカテゴリ一覧
スマートグリッド
お問合わせはこちらから
